Tyler Redman

Tyler Redman has a strong background in the biopharmaceutical industry, with expertise in manufacturing science and technology. Tyler is currently working at Senti Biosciences as the Director of MSAT & Manufacturing. Prior to this, they held the position of Associate Director of Manufacturing Science and Technology at Nutcracker Therapeutics, where they were responsible for facility design and construction of a clinical GMP Manufacturing suite. Tyler also worked as a Sr. Scientist in Process Development at Nutcracker Therapeutics. Before joining Nutcracker Therapeutics, Tyler worked at AveXis, Inc. as a Scientist in Analytical Science and Technology and as an Engineer in Manufacturing Science and Technology, where they were involved in developing and managing process designs and control strategies for gene therapy products. Tyler also played a role in providing technical support for process improvements and managing multiple process improvement initiatives. Prior to AveXis, Tyler worked at Crestovo LLC (now Finch Therapeutics) as a Research Associate and Manufacturing Specialist, where they oversaw the development of analytical assays and provided technical support to clinical stage manufacturing operations. Tyler started their career as a Research Scientist Intern at Promega and as an Undergraduate Research Assistant at the University of Wisconsin-Madison, School of Medicine and Public Health.

Tyler Redman earned a Bachelor of Science degree in Biology from the University of Wisconsin-Madison from 2013 to 2016. Following this, they pursued further education and obtained an MBA from the University of Wisconsin MBA Consortium from 2018 to 2021.